首页> 外文OA文献 >Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study

【2h】

Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study

机译：与奥美拉唑20mg患者在非腐蚀反流疾病患者中相比，Albisd的疗效和安全性：随机，开放标签，主动控制，试验研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Eun Jin Kim; Oh Young Lee; Kang Nyeong Lee; Sung Joon Lee; Jae-Young Jang; Jin Woong Cho; Tae-Oh Kim;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Efficacy and safety of AlbisD (R) in patients with nonerosive reflux disease: A randomized, open-label, active-controlled, pilot study compared with omeprazole 20 mg [J] . Lee S. -P., Lee O. -Y., Kim E. -J., Neurogastroenterology and motility . 2018,第S1期

机译：与Omeprazole 20毫克相比，Albisd（R）在非耐回流疾病患者中的疗效和安全性：随机，开放标签，主动控制的试验研究相比
2. Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind, placebo-controlled study. [J] . Miwa H, Inoue K, Ashida K, Alimentary pharmacology & therapeutics. . 2011,第3期

机译：随机临床试验：在奥美拉唑中添加促运动的莫沙必利柠檬酸盐治疗非侵蚀性反流性疾病的疗效-一项双盲，安慰剂对照研究。
3. Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease?–?a double-blind, placebo-controlled study [J] . H. Miwa, K. Inoue, K. Ashida, Alimentary Pharmacology & Therapeutics . 2011,第3期

机译：随机临床试验：在奥美拉唑中添加促运动的莫沙必利柠檬酸盐治疗非侵蚀性反流性疾病的疗效？–一项双盲，安慰剂对照研究
4. An open-label, multicenter, randomized,comparative, safety, efficacy, cycle control,and quality of life study of CTR 25, Alesse ,and Ortho Tri-Cyclen [C] . Victoria Davis, Brian Hauck, Sheila Dunn, World Congress on Fertility and Sterility . 2004

机译：开放标签，多中心，随机，比较，安全，疗效，循环控制和CTR 25，Alesse和Ortho Tri-Cyclen的生命研究
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized Open-label Active-controlled Pilot Study [O] . Eun Jin Kim, Oh Young Lee, Kang Nyeong Lee, 2019

机译：AlbisD与奥美拉唑20 mg在非糜烂性反流疾病患者中的疗效和安全性：一项随机开放标签主动控制的先导研究
7. A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years. [O] . Thjodleifsson, B, Rindi, G, Fiocca, R, 2003

机译：10或20 mg雷贝拉唑与20 mg奥美拉唑相比在5年内维持胃食管反流疾病的有效性和安全性的随机，双盲试验。

Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study

著录项

引文网络

相似文献

相关主题

期刊订阅